Skip to content

To evaluate the safety and efficacy of laparoscopic laparoscopic radical resection of colorectal cancer

To evaluate the safety and efficacy of laparoscopic laparoscopic radical resection of colorectal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084449
Enrollment
Unknown
Registered
2024-05-16
Start date
2024-01-22
Completion date
Unknown
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radical resection of colorectal cancer

Interventions

Test group:Endoscopic abdominal surgery system

Sponsors

The Second Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients with clinical diagnosis of colorectal cancer and clinical stage I-IIIB, requiring radical resection of colorectal cancer; (2) There was no extensive invasion or distant metastasis in imaging examination; (3) Age 18-75 years old (inclusive), gender is not limited; (4) Be able to cooperate with and complete follow-up and related examinations; (5) Voluntarily participate in this experiment and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Exclude patients with familial adenomatous polyposis and ulcerative colitis cancer; (2) Patients involving surrounding organs requiring combined organ resection, CRM(+) of rectal cancer, and R0 resection is not expected; (3) severe coagulation dysfunction, obvious bleeding tendency; (4) Patients with severe comorbidities who cannot tolerate surgery or anesthesia; (5) Severely obese people with BMI > 30 kg/m2; (6) Patients with intestinal obstruction, bleeding or perforation requiring emergency surgery; (7) Pregnant or lactating women; (8) Participants in other investigational drug or device clinical trials have not been completed; (9) Patients considered unsuitable for this program by the investigator.

Design outcomes

Primary

MeasureTime frame
Rate of unconverted surgery;

Secondary

MeasureTime frame
Operation time;Intraoperative bleeding;Intraoperative blood transfusion;

Countries

China

Contacts

Public ContactWang Guiyu

The Second Affiliated Hospital of Harbin Medical University

Wangguiyv@163.com+86 139 4513 3256

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026